The Senate Legal and Constitutional Sub-Committee is conducting an inquiry into appropriate terms of reference for a COVID-19 Royal Commission. We made a submission.

Our submission concentrated mostly on governance issues to do with how policies were adopted and who was making the decisions. It also dealt with the increase in excess mortality (and the consequent decrease in life-expectancy).

You can download the submission by clicking here.

The substantive part of the submission was our suggested terms of reference which were:

That a Commissioner be appointed to inquire into all matters concerning the Commonwealth government’s policies and actions with respect to public health, economic and other matters concerning the COVID-19 pandemic in 2020 and following included, but not limited to:

1. matters pertaining to governance including but not limited to:
   • (i) the adequacy of pre-existing pandemic plans and their relationship to policy that was actually implemented during the pandemic, including any data or information which might exist to support or otherwise those policies;
   • (ii) the process by which licensing bodies approve medications, including vaccines, for use;
   • (iii) the appropriateness of using states of emergency in pandemic situations;
   • (iv) the appropriateness of the make-up of bodies charged with setting policies;
   • (v) the role of regulatory authorities, including but not limited to bodies tasked with approving drugs and regulating the medical professions.
2. matters pertaining to the effects of the policies that were implemented including but not limited to:
   • (i) the effectiveness and costs and benefits of policies including lockdowns and vaccinations to the community and to the individual; and
   • (ii) the extent of vaccine injury and how it relates to other vaccines.
3. matters pertaining to legal and ethical issues including, but not limited to:

• • (i) Australia’s responsibilities under international conventions, covenants and treaties with special reference to vaccine mandates imposed by governments and private corporations; and
  • (ii) the role of the Human Rights Commission.

1. matters pertaining to the quality of the data available to decision makers and the public including, but not limited to:
   • (i) the adequacy of data and the form in which it is reported; and
   • (ii)
2. Matters pertaining to government drug procurement for treatment of COVID-19 including, but not limited to:
   • (i) the types of drugs that were purchased;
   • (ii) the amounts of drugs that were purchased; and
   • (iii) the purchasing process, including the cost to the Commonwealth.